• Skip to table of contents
  • Skip to main content
  • Skip to footer
IMPLICIT Network

IMPLICIT Network

Innovations for Maternal and PerinataL Care ImprovemenT

  • Home
  • About
    • About IMPLICIT
    • Where We Work
    • Meet the Team
    • FAQs
    • Contact
  • Projects
    • Interconception Care – ICC
    • 4th Trimester – 4TM
    • Committees
  • Resources
  • News
  • Support
  • Membership

Search IMPLICIT Network

Innovations for Maternal and PerinataL Care ImprovemenT

Innovative care
to improve birth outcomes
and support families to thrive

The IMPLICIT Network develops, implements, evaluates, and optimizes new and existing models of care focused on improving birth outcomes and the health of mothers/birthing people, infants, and families.

Learn More

Care Models

Interconception Care (ICC)

This model focuses on screening mothers/birthing people for smoking, depression, family planning, and multivitamin with folic acid intake during baby’s well child visits 0-24 months.

4th Trimester (4TM)

This model aims to improve the health of families by redefining postpartum care for mothers/birthing people by assessing of conditions and risks in the prenatal and intrapartum period.

Our Impact

States
Sites
Mother/birthing people and baby dyads

Where We Serve

Join Us in This Work

Footer

Get the Latest

Thank you to all those who attended our annual Fal Thank you to all those who attended our annual Fall Meeting this year! We loved connecting with our site champions, prospective sites, and medical students and residents. 

The Fall Meeting provides an opportunity for members of the IMPLICIT Network to come together, celebrate the accomplishments of the past year, share best practices, and discuss priorities and goals for the upcoming year. 

In conjunction with the Fall Meeting, the IMPLICIT team also enjoyed attending and tabling at the 2026 Family Medicine Education Consortium (FMEC) Annual Meeting. Team members presented on maternal depression screening during well child visits from 0-24 months, as well as findings from a mixed-methods evaluation of Pennsylvania IMPLICIT sites. 

Interested in learning more about the IMPLICIT Network? Visit our website (linked in our bio). 

#IMPLICITNetwork #ICC #4thtrimester #FMEC
IMPLICIT program coordinators, Emily and Aisha, at IMPLICIT program coordinators, Emily and Aisha, attended the annual Family Medicine Midwest conference in Indianapolis, Indiana earlier this month. 

Family Medicine Midwest is a collaborative effort across multiple states in the Midwest, committed to building a strong family medicine workforce. 

Emily and Aisha presented on the IMPLICIT Network structure, care models, and how to get involved. 

#IMPLICITNetwork #interconceptioncare #4thtrimester #FamilyMedicineMidwest #fmmmidwest26
We are excited to welcome Tegan Hagy to our team! We are excited to welcome Tegan Hagy to our team!

Tegan is a graduate of Penn's Master of Public Health program and brings more of 20 years of experience in advancing public health through project implementation, program management, and policy development. Her background includes work with the Philadelphia Department of Public Health, The Food Trust and The Common Market, as well as leadership roles with the USDA's Food and Nutrition Service, where she supported community food system development across multiple states. Tegan is passionate about maternal and child health, is a trained doula and certified lactation counselor, and is delighted to return to Penn supporting the IMPLICIT Network. Tegan lives in Philadelphia with her unruly garden, two children, and four chickens.

#IMPLICITNetwork #maternalchildhealth
Preeclampsia is a hypertensive disorder that is a Preeclampsia is a hypertensive disorder that is a complication of pregnancy. It is characterized by high blood pressure and often the presence of protein in the urine. If left untreated, it can lead to serious complications for the mother/birthing person and baby. 

Low-dose aspirin (LDA), taken daily during pregnancy, can prevent or delay the onset of preeclampsia. If a mother/birthing person has risk factors for preeclampsia it is recommended, after consultation with the patient's provider, that daily LDA supplementation begins late in the first trimester. 

For providers, the Hypertension in Pregnancy Change Package (HPCP) can be utilized to put more efficient and effective systems in place to care for birthing people with hypertension in pregnancy. The HPCP outlines the evidence and indications of LDA use in pregnancy to prevent preeclampsia. 

#IMPLICITNetwork #HypertensiveDisorders #Preeclampsia #LowDoseAspirin
Follow on Instagram

Copyright © 2026 · IMPLICIT Network · All Rights Reserved · Website by Tomatillo Design